$23.92
0[0.00%]
At close: Apr 22
$23.92
0[0.00%]
PreMarket: 4:00PM EDT
Arrowhead Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Arrowhead Pharma using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/07/2024 | PM | ARWR | Q2 | $0.45 | -$0.16 | — | — | $146.27M | $63.87M | — | — | Get Alert |
02/06/2024 | PM | ARWR | Q1 | -$0.39 | -$0.82 | -$1.24 | -51.22% | $62.55M | $29.51M | $3.55M | -87.97% | Get Alert |
11/29/2023 | PM | ARWR | Q4 | -$0.81 | -$0.60 | -$1.02 | -70.00% | $31.57M | $50.73M | $16.10M | -68.27% | Get Alert |
08/07/2023 | PM | ARWR | Q3 | -$0.68 | -$0.58 | -$0.96 | -65.52% | $32.41M | $48.19M | $15.82M | -67.16% | Get Alert |
05/02/2023 | PM | ARWR | Q2 | $0.41 | -$0.64 | $0.45 | 170.31% | $151.81M | $45.48M | $146.27M | 221.61% | Get Alert |
02/06/2023 | PM | ARWR | Q1 | -$0.60 | $0.44 | -$0.39 | -188.64% | $27.44M | $162.52M | $62.55M | -61.51% | Get Alert |
11/28/2022 | PM | ARWR | Q4 | -$0.61 | -$0.16 | -$0.81 | -406.25% | $38.28M | $50.44M | $31.57M | -37.40% | Get Alert |
08/04/2022 | PM | ARWR | Q3 | -$0.29 | -$0.51 | -$0.68 | -33.33% | $45.89M | $55.23M | $32.41M | -41.31% | Get Alert |
05/10/2022 | PM | ARWR | Q2 | -$0.26 | -$0.08 | $0.41 | 612.50% | $32.81M | $108.91M | $151.81M | 39.39% | Get Alert |
02/02/2022 | PM | ARWR | Q1 | -$0.20 | -$0.45 | -$0.60 | -33.33% | $21.30M | $51.04M | $27.44M | -46.24% | Get Alert |
11/22/2021 | PM | ARWR | Q4 | -$0.48 | -$0.10 | -$0.61 | -510.00% | $7.63M | $56.77M | $38.28M | -32.56% | Get Alert |
08/05/2021 | PM | ARWR | Q3 | -$0.13 | -$0.20 | -$0.29 | -45.00% | $27.38M | $37.52M | $45.89M | 22.31% | Get Alert |
05/04/2021 | PM | ARWR | Q2 | -$0.20 | -$0.13 | -$0.26 | -100.00% | $23.53M | $37.70M | $32.81M | -12.97% | Get Alert |
02/04/2021 | PM | ARWR | Q1 | -$0.03 | $0.17 | -$0.20 | -217.65% | $29.45M | $86.69M | $21.30M | -75.43% | Get Alert |
11/23/2020 | PM | ARWR | Q4 | $0.11 | $0.12 | -$0.48 | -500.00% | $43.29M | $49.24M | $7.63M | -84.50% | Get Alert |
08/05/2020 | PM | ARWR | Q3 | $0.21 | -$0.12 | -$0.13 | -8.33% | $42.70M | $28.91M | $27.38M | -5.31% | Get Alert |
05/07/2020 | PM | ARWR | Q2 | $0.24 | -$0.11 | -$0.20 | -81.82% | $48.15M | $21.74M | $23.53M | 8.23% | Get Alert |
02/05/2020 | PM | ARWR | Q1 | $0.13 | -$0.01 | -$0.03 | -200.00% | $34.66M | $29.50M | $29.45M | -0.15% | Get Alert |
11/25/2019 | PM | ARWR | Q4 | -$0.12 | — | $0.11 | — | $11.26M | — | $43.29M | — | Get Alert |
Arrowhead Pharma (ARWR) is scheduled to report earnings on May 7, 2024. The last reported earnings were for reported on February 6, 2024 for Q1.
The Actual EPS was $-1.24, which missed the estimate of $-0.82.
The Actual Revenue was $3.6M, which missed the estimate of $29.5M.
Browse earnings estimates, EPS, and revenue on all stocks.